The Federal Law That Requires Coverage: MHPAEA Explained
The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 requires most health insurance plans to cover substance use disorder (SUD) treatment at the same level as medical and surgical benefits. Insurers cannot impose more restrictive limits — tighter day limits, higher copays, or stricter prior authorization criteria — on addiction treatment than they apply to comparable medical care. MHPAEA is the core federal protection for anyone using insurance to pay for rehab. (Source: U.S. Department of Labor, Employee Benefits Security Administration)
MHPAEA applies to: employer-sponsored health plans with 50 or more employees, individual and small group plans purchased on ACA marketplaces (healthcare.gov), Medicaid managed care plans, and CHIP (Children's Health Insurance Program). Plans generally excluded include grandfathered health plans predating the ACA, self-insured plans for small employers without applicable state parity laws, and short-term limited-duration insurance.
Parity in practice means: if your plan covers a 10-day hospital stay for a medical condition, it cannot limit inpatient psychiatric or SUD care to fewer days using a stricter standard. If your plan covers outpatient medical visits at a $30 copay, it must apply comparable cost-sharing to outpatient addiction therapy sessions. MHPAEA is enforced jointly by the U.S. Department of Labor (employer plans), HHS (individual/Medicaid plans), and the Treasury Department.
Parity violations remain common. The American Psychiatric Association, state attorneys general, and the U.S. Government Accountability Office have all documented widespread insurer non-compliance — particularly in prior authorization criteria applied more aggressively to SUD care than to comparable medical conditions. Consumers who believe their insurer is violating parity can file complaints at Healthcare.gov or with their state insurance commissioner.
Insurance Coverage by Plan Type: Private, Medicaid & Medicare
Insurance covers addiction treatment across all major plan types — private employer-sponsored plans, Medicaid, and Medicare — though coverage details, cost-sharing requirements, and prior authorization rules differ meaningfully by plan type.
Private and Employer-Sponsored Insurance
Employer-sponsored insurance covers approximately 54% of Americans under age 65. Plans with 50 or more employees must comply with MHPAEA. Typical private coverage includes inpatient rehab for 28-30 days per benefit year with prior authorization; extensions require concurrent review every 3-7 days with updated clinical documentation. Individual deductibles average $1,763 for employer-sponsored plans and $1,992 for ACA marketplace plans in 2024. (Source: KFF Employer Health Benefits Survey, 2024)
ACA marketplace plans treat substance use disorder treatment as an essential health benefit — all plans must cover it regardless of medical history. Open enrollment runs November 1 – January 15. Special enrollment periods are available for qualifying life events including job loss, marriage, and birth of a child.
Medicaid
Medicaid covers substance use disorder treatment in all 50 states and DC. The 41 states plus DC that expanded Medicaid under the ACA extend eligibility to adults earning up to 138% of the federal poverty level (approximately $20,783/year for an individual in 2024). Non-expansion states — including Texas, Florida, Georgia, Alabama, Mississippi, Wyoming, Kansas, and Wisconsin — use narrower eligibility criteria. (Source: Kaiser Family Foundation, Status of State Medicaid Expansion Decisions, 2024)
Medicaid SUD benefits typically include: medical detox, inpatient residential treatment, partial hospitalization (PHP), intensive outpatient (IOP), standard outpatient therapy, MAT medications (buprenorphine and naltrexone in all programs; methadone in most states), peer support services, and case management. Cost-sharing is minimal or zero for most Medicaid enrollees; Medicaid managed care plans must comply with MHPAEA.
Medicare
Medicare provides SUD treatment coverage across its component parts:
- Part A (Hospital Insurance) — Covers inpatient hospital-based detox and residential treatment in Medicare-certified hospital settings. After the $1,632 per-benefit-period deductible (2024), Medicare covers days 1-60 with no daily coinsurance.
- Part B (Medical Insurance) — Covers IOP services (minimum 3 hours/day, 3 days/week in approved programs), outpatient therapy visits (20% coinsurance after the $240 annual deductible), and physician office visits for SUD diagnosis and treatment management.
- Opioid Treatment Program (OTP) Benefit — Since January 2020, Medicare bundles payment for OTP services: methadone dispensing, individual and group counseling, toxicology testing, and care coordination. This is a weekly bundled payment to certified OTPs.
- Part D (Prescription Drug Coverage) — Covers buprenorphine (Suboxone and generics), oral naltrexone, and on most plans, injectable naltrexone (Vivitrol). Prior authorization is commonly required for Vivitrol.
Medicare Advantage (Part C) plans often provide additional SUD benefits beyond Original Medicare, including enhanced MAT coverage, telehealth addiction treatment visits, and transportation to treatment facilities.
What Addiction Treatment Is Covered by Insurance?
Insurance covers the full continuum of evidence-based addiction treatment — from medical detox through inpatient residential care, partial hospitalization, intensive outpatient, standard outpatient, and medication-assisted treatment (MAT). Under MHPAEA, coverage at each level must be comparable to medical/surgical equivalent benefits.
| Level of Care | ASAM Level | Typical Coverage | Prior Auth? |
|---|---|---|---|
| Medical Detox | 3.7 / 4.0 | 3–14 days | Usually |
| Inpatient / Residential | 3.1 – 3.5 | 14–30 days (extensible) | Yes |
| Partial Hospitalization (PHP) | 2.5 | 5–6 hrs/day, 5 days/wk | Usually |
| Intensive Outpatient (IOP) | 2.1 | 9–15 hrs/week | Sometimes |
| Standard Outpatient | 1.0 | 1–2 sessions/week | Rarely |
| MAT (Buprenorphine, Naltrexone, Methadone) | All levels | Ongoing | Often (Vivitrol) |
Insurance also covers dual diagnosis treatment for co-occurring mental health conditions, psychiatric medications, individual and group therapy components, and case management during active treatment. MAT medications (buprenorphine, naltrexone, acamprosate, disulfiram) are covered under prescription drug benefits (Part D for Medicare; pharmacy benefit rider for private plans). Methadone for opioid use disorder is dispensed at certified OTPs and billed separately from pharmacy benefits.
What Insurance Typically Does Not Cover
Most plans exclude: luxury amenities at high-end centers (private rooms, equine therapy, spa treatments, gourmet meal service); room and board at sober living homes or halfway houses — only active treatment services are reimbursable; experimental or non-evidence-based treatments; out-of-network facilities at in-network cost-sharing rates (unless a network adequacy exception applies); and transportation to and from treatment. Non-licensed or non-accredited facilities may be excluded from coverage entirely.
Prior Authorization for Rehab: What to Expect
Prior authorization (pre-authorization or pre-certification) is written approval from your insurer required before treatment begins. The insurer evaluates your clinical information to confirm medical necessity and appropriate level of care — typically using ASAM patient placement criteria. Prior auth is required for virtually all inpatient admissions and most PHP/IOP programs.
Timeline: Federal law requires insurers to respond to urgent prior authorization requests within 72 hours. Standard (non-urgent) requests must be processed within 3-5 business days. If treatment is medically urgent — active withdrawal, imminent overdose risk — facilities can admit under concurrent authorization while submitting documentation simultaneously.
What insurers evaluate: ASAM criteria dimensions including withdrawal severity, biomedical complications, emotional/behavioral conditions, motivation and readiness to change, relapse potential, and recovery environment stability. The clinical documentation submitted by the treatment facility's utilization review (UR) team is what determines approval or denial.
Key tip — have the facility submit authorization, not yourself. Treatment facilities' UR teams know exactly which CPT codes to use, which clinical criteria to document for each payer, and how to navigate specific insurers' requirements. Self-submitted authorizations without UR expertise have significantly higher denial rates.
Concurrent review: For inpatient stays, your insurer reviews continued medical necessity every 3-7 days throughout treatment. The clinical team provides updated documentation. Discharge planning begins from the first day — insurers push toward step-down care (residential → PHP → IOP → outpatient) rather than extended inpatient stays without documented clinical justification.
Out-of-Pocket Costs for Rehab With Insurance
Even with insurance, expect out-of-pocket costs — deductible, copays or coinsurance, and potentially out-of-network charges if your preferred facility isn't in your plan's network. Understanding these costs before admission prevents financial surprises and helps you choose the right facility.
- Deductible: The amount you pay before insurance begins covering costs. Averages $1,763/year for individual employer-sponsored coverage; $1,992 for ACA marketplace plans (KFF, 2024). If your deductible is already met for the calendar year, treatment admission may cost significantly less.
- Copay/Coinsurance (in-network): After meeting your deductible, expect 10-30% coinsurance or a flat copay — commonly $150-300/day for in-network inpatient stays — for the remainder of your stay.
- Out-of-network coinsurance: Typically 30-50% after a separate out-of-network deductible. Some HMO plans cover zero out-of-network care except emergencies.
- Out-of-pocket maximum: ACA-compliant plans cap annual out-of-pocket costs at $9,450 (individual) / $18,900 (family) in 2024. Once your OOP maximum is reached, insurance covers 100% of in-network costs for the rest of the benefit year.
- Medicaid: Minimal or zero cost-sharing for most enrollees. Some states charge nominal copays ($1-4 per visit or service).
- Medicare: $1,632 inpatient deductible per benefit period (2024); no daily coinsurance for days 1-60; 20% coinsurance for Part B outpatient services after the $240 annual deductible.
When Insurance Denies Coverage: Your Rights & Appeals
Insurance denials for addiction treatment are common — but not final. Federal law gives you the right to appeal, and many denials are overturned on internal or external review, particularly when the denial constitutes a MHPAEA parity violation.
Common Reasons for Denial
- Medical necessity not established — Insurer claims your condition doesn't meet criteria for the requested level of care based on ASAM criteria review
- Level of care deemed excessive — Insurer approves a lower level than clinically indicated (IOP instead of inpatient)
- Out-of-network provider — Facility not in plan's network; insurer applies out-of-network cost-sharing or full denial under HMO rules
- Benefits exhausted — Annual day or visit limit reached (increasingly challenged under MHPAEA)
- Non-covered service — Specific service (room and board at sober living, luxury amenities) isn't a covered plan benefit
Step 1: Internal Appeal
File your internal appeal in writing within 60 days of the denial. Submit supporting clinical documentation — ASAM assessment, physician letter of medical necessity, treatment records, relevant research supporting the requested level of care. The insurer must respond within 30 days (standard appeal) or 72 hours (urgent expedited appeal for situations involving imminent health risk).
Step 2: External Review
If the internal appeal fails, request independent external review through a state-certified Independent Medical Review Organization (IMRO). An independent, board-certified physician reviews your case. The IMRO's decision is binding on the insurance company — if the IMRO finds the denial improper, the insurer must cover the treatment. External review is available for most denied claims exceeding $100.
Step 3: Regulatory Complaint
File a complaint with your state insurance commissioner (for individual market plans) or the U.S. Department of Labor Employee Benefits Security Administration (for employer-sponsored plans). MHPAEA violations — demonstrating that the insurer applied more restrictive SUD standards than comparable medical/surgical benefits — are a strong basis for regulatory action and can result in coverage being mandated retroactively.
How to Verify Your Insurance Benefits for Rehab
Insurance verification takes 15-30 minutes when done systematically. Call the member services number on the back of your insurance card and ask these specific questions:
- Is inpatient substance abuse treatment a covered benefit under my plan? Ask them to confirm it's not excluded or carved out.
- What is my individual deductible, and how much has been applied this calendar year?
- What are my copays or coinsurance for inpatient mental health or SUD treatment at an in-network facility?
- Is prior authorization required for inpatient admission? For PHP? For IOP? For MAT medications?
- What is the annual limit on covered inpatient days for SUD treatment?
- Which inpatient SUD treatment facilities are in-network near [your city or zip code]?
- Are MAT medications — buprenorphine (Suboxone), injectable naltrexone (Vivitrol) — covered under my pharmacy benefit?
- What is my individual out-of-pocket maximum for this benefit year?
Always request a reference number at the end of the call and note the representative's name. Written documentation of your verification call protects you in the event of a billing dispute. If in-network facility options in your area are limited, ask the insurer specifically about their network adequacy standards and exception process.
Alternatively — our advisors verify for you, free. We make this call daily for families navigating treatment. We confirm covered services, deductible status, in-network facilities, and prior authorization requirements in one call and give you a clear summary before you choose a facility. Available 24 hours a day, 7 days a week.
Sources & References
- U.S. Department of Labor. Mental Health Parity and Addiction Equity Act (MHPAEA). Public Law 110-343, 2008.
- Kaiser Family Foundation (KFF). Employer Health Benefits Survey 2024.
- Kaiser Family Foundation (KFF). Status of State Medicaid Expansion Decisions, 2024.
- Centers for Medicare & Medicaid Services (CMS). Medicare Coverage of Substance Abuse Treatment, 2024.
- SAMHSA. National Survey on Drug Use and Health (NSDUH), 2023.
- American Psychiatric Association. Parity or Disparity: The State of Mental Health in America 2023.
- U.S. Government Accountability Office (GAO). Mental Health Parity: Improved Oversight Needed. GAO-22-104787, 2022.